NR1H4 and hepatocellular carcinoma: Collectively, these findings propose that Linolenate [α or γ; (18:3n3 or 6)] could serve as a mediator, potentially regulating the FXR/Wnt/β-catenin signaling pathway, thereby modulating the immunocyte effects on HCC.